Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Long-term outcome after ECT for catatonic depression.

C M Swartz1, V Morrow, L Surles

  • 1Department of Psychiatry, Southern Illinois University School of Medicine, Springfield, Illinois 62794-9642, USA. ectdoc@pol.net

The Journal of ECT
|August 31, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Note on Teeth in the Indian Army.

The Indian medical gazette·2017
Same author

How to Examine Recruits.

The Indian medical gazette·2017
Same author

Treatment of Soft Sore and Bubo.

The Indian medical gazette·2017
Same author

Quinine Prophylaxis and Other Notes on Malaria.

The Indian medical gazette·2017
Same author

A Note on the Treatment of Tropical Ulcer.

The Indian medical gazette·2017
Same author

A Simple Fly Trap.

The Indian medical gazette·2017
Same journal

Successful Use of Electroconvulsive Therapy in Treatment-Resistant Catatonia With Comorbid Parkinson Disease and Neuroborreliosis: A Case Report.

The journal of ECT·2026
Same journal

Electroconvulsive Therapy in Movement Disorders: A Systematic Review.

The journal of ECT·2026
Same journal

Presyncope During Repetitive Transcranial Magnetic Stimulation With Treatment Continuation.

The journal of ECT·2026
Same journal

Comparison of Electroconvulsive Therapy Seizure Outcomes When Using Methohexital Versus Propofol: A Brief Retrospective Report.

The journal of ECT·2026
Same journal

Changes in the Use of Repetitive Transcranial Magnetic Stimulation Therapy Between 2016 and 2022 in Northern Finland.

The journal of ECT·2026
Same journal

Evaluation of Cardiac Adverse Effects After Transition From Bitemporal to Bifrontal ECT.

The journal of ECT·2026
See all related articles

Electroconvulsive therapy (ECT) followed by antimelancholic medication (AMM) significantly improved long-term outcomes for major depression with catatonic features compared to other treatments. AMM use was associated with better functioning and reduced mortality.

Area of Science:

  • Psychiatry
  • Neuroscience
  • Clinical Medicine

Background:

  • Major depression with catatonic features is a severe condition requiring effective long-term management strategies.
  • Electroconvulsive therapy (ECT) is an established treatment for catatonic depression, but its long-term efficacy depends on post-hospitalization care.

Purpose of the Study:

  • To report the long-term course of major depression with catatonic features after inpatient electroconvulsive therapy (ECT).
  • To compare outcomes for patients receiving antimelancholic medication (AMM) versus those not receiving AMM after ECT.

Main Methods:

  • A follow-up study involving telephone interviews and ratings conducted 3-7 years post-ECT for 19 patients with catatonic depression.
  • Patients received left anterior right temporal brief-pulse ECT.

Related Experiment Videos

  • Antimelancholic medications (AMM) were defined by specific criteria, including lithium, tricyclics, bupropion, and venlafaxine, excluding SSRIs.

    • Main Results:

    • Ten of 13 patients discharged on AMM showed good long-term function with minimal rehospitalization.
    • None of the six patients not on AMM achieved similar outcomes (p = 0.004).
    • The AMM group had no deaths, while three patients in the other group died from cardiopulmonary causes (p = 0.015).

    Conclusions:

    • ECT followed by AMM generally results in good long-term outcomes for catatonic depression, superior to treatment without AMM.
    • Long-term use of benzodiazepines for catatonia remains speculative due to a lack of supporting long-term studies.